A Study of Evolocumab on Carotid Artery Atherosclerotic Plaque Morphology Prior to Carotid EndArterectomy
Status:
Recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, open label study with blinded outcome assessment to
evaluate the impact of additional/intensive LDL-cholesterol reduction with evolocumab on
carotid artery atherosclerotic plaques in higher risk subjects with severe asymptomatic but
vulnerable plaques.
Phase:
Phase 4
Details
Lead Sponsor:
Canadian Medical and Surgical Knowledge Translation Research Group